Přihlásit se Zaregistrujte se zdarma

Příjmy společnosti AC Immune SA

Jaká je hodnota metriky Příjmy společnosti AC Immune SA?

Hodnota metriky Příjmy společnosti AC Immune SA je -CHF73.28

Jaká je definice metriky Příjmy?

Výsledek příjmů pro kmenové akcionáře (Income) se rovná celkovému příjmu sníženému o přednostně vyplacené dividendy.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Příjmy společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností AC Immune SA

Čemu se věnuje společnost AC Immune SA?

ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor

Firmy s metrikou příjmy podobnou společnosti AC Immune SA